Zobrazeno 1 - 10
of 131
pro vyhledávání: '"W. O. Richter"'
Publikováno v:
Journal of Lipid Research, Vol 37, Iss 11, Pp 2383-2393 (1996)
Apheresis is a treatment option for patients with severe hypercholesterolemia and coronary artery disease. It is, however, unknown whether such therapy changes kinetic parameters of lipoprotein metabolism, such as apolipoprotein B (apoB) secretion ra
Externí odkaz:
https://doaj.org/article/39c926d0364f4a999d60f6a05edbd809
Publikováno v:
DMW - Deutsche Medizinische Wochenschrift. 115:1665-1669
Publikováno v:
DMW - Deutsche Medizinische Wochenschrift. 114:899-902
Insulin treatment in 34 type I diabetics (17 women and 17 men; mean age 30.6 [13-72] years) was changed from a conventional to an intensified conventional treatment schedule (ICIT). However, optimal metabolic control was possible in the long term in
Publikováno v:
ASAIO Journal. 43:53-59
Publikováno v:
Hepatology. 24:1334-1337
High serum concentrations of lipoprotein (a) [Lp(a)] are considered a risk factor for premature atherosclerosis. Besides apolipoprotein B-100, Lp(a) consists of apolipoprotein (a) [apo(a)], which shows a remarkable size polymorphism. The serum concen
Publikováno v:
European Journal of Clinical Investigation. 25:258-265
In order to evaluate whether changes in plasma phospholipid composition are rapidly transmitted to the red blood cell membrane (RBCM) under in vivo conditions, the levels of major phospholipids in plasma, low density and high density lipoproteins (LD
Autor:
P. SCHUFF-WERNER, H. GOHLKE, U. BARTMANN, G. BAGGIO, M. C. CORTI, A. DINSENBACHER, T. EISENHAUER, P. GRÜTZMACHER, C. KELLER, U. KETTNER, W. KLEOPHAS, W. KÖSTER, C. J. OLBRICHT, W. O. RICHTER, D. SEIDEL, THE HELP-STUDY GROUP
Publikováno v:
European Journal of Clinical Investigation. 24:724-732
The efficacy of the heparin-induced extracorporeal LDL-precipitation (HELP)-apheresis procedure has been studied in an open prospective multicentre trial. After 2 years of regular weekly HELP-treatment the data from 39 of 51 patients could be evaluat
Autor:
L, Magenta, S, Dell-Kuster, W O, Richter, J, Young, B, Hasse, M, Flepp, B, Hirschel, P, Vernazza, J, Evison, M, Cavassini, L A, Decosterd, H C, Bucher, E, Bernasconi, S, Yerly
Publikováno v:
AIDS research and human retroviruses. 27(5)
We characterized lipid and lipoprotein changes associated with a lopinavir/ritonavir-containing regimen. We enrolled previously antiretroviral-naive patients participating in the Swiss HIV Cohort Study. Fasting blood samples (baseline) were retrieved
Publikováno v:
European Journal of Clinical Pharmacology. 42:353-358
The effects of the HMG CoA reductase inhibitors lovastatin and pravastatin on serum lipids, lipoproteins and apolipoproteins have been studied in 35 patients with primary hypercholesterolaemia. LDL cholesterol was lowered to the same extent by both a